← All Sponsors
SPONSOR

Kailin Yang, MD, PhD

Total Trials
1
Recruiting
1
Phases
Phase 1

Kailin Yang, MD, PhD is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Glioma, Glioblastoma, Recurrent Glioma, Recurrent Glioblastoma.

The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Kailin Yang, MD, PhD

How many clinical trials has Kailin Yang, MD, PhD sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Kailin Yang, MD, PhD, of which 1 are actively recruiting participants. These trials cover conditions including Glioma, Glioblastoma, Recurrent Glioma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Kailin Yang, MD, PhD research focus on?
Kailin Yang, MD, PhD clinical trials span Glioma, Glioblastoma, Recurrent Glioma, Recurrent Glioblastoma, Grade 4 Malignant Glioma of Brain (Disorder). The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Kailin Yang, MD, PhD clinical trial?
To participate in a Kailin Yang, MD, PhD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Kailin Yang, MD, PhD trials with current recruitment status updated daily.

Clinical Trials by Kailin Yang, MD, PhD

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology